Peptides DB
Research-centric peptide and protocol reference hub
Study 2 of 15Bofanglutide literatureVirulence · Observational2025

Giardiavirus rewires host translation and glycolytic metabolism to support its replication in <i>Giardia duodenalis</i>.

Giardiavirus infection alters the metabolic pathways of Giardia duodenalis, particularly enhancing glycolysis, which may have implications for future research on giardiasis treatment.

Read at VirulenceAdd to compare

Where it sits

this study against the rest of the bofanglutide corpus
5
Preclinical
4
Observational · this one
0
Open-label
2
Randomised
4
Reviews

Summary and findings

This study investigates the effects of Giardiavirus (GLV) on the intestinal protozoan parasite Giardia duodenalis, focusing on its impact on protein expression and metabolic pathways. The research found that GLV infection reduced mRNA and protein levels of Giardia genes while enhancing mRNA translation efficiency. Additionally, GLV infection altered energy metabolism, particularly glycolysis, with 21 significantly altered energy metabolites identified.

How much of this paper we could read: full text read (0.70). We had a clear abstract, so the summary below closely tracks the paper. What this means →
Not reported in abstract.2025

Abstract

The authors’ words, as Virulence supplied them

<i>Giardia duodenalis</i> is an intestinal protozoan parasite responsible for giardiasis, a disease primarily characterized by diarrhea and associated with long-term complications such as malnutrition and growth impairment in children. The presence of Giardiavirus (GLV) has been shown to attenuate pathological damage in <i>G. duodenalis</i>-infected murine models and modulate distinct pro-inflammatory responses in host cells stimulated by <i>Giardia</i>. However, the understanding of the impact of the GLV on the <i>G. duodenalis</i> itself remains limited. Here, we found that GLV infection interfered with the host protein expression system by reducing both mRNA and protein levels of <i>Giardia</i> genes, while paradoxically enhancing mRNA translation efficiency. Additionally, GLV infection induced energy metabolic reprogramming in <i>Giardia</i>, as evidenced by the identification of 21 significantly altered energy metabolites. KEGG enrichment analysis revealed glycolysis/gluconeogenesis as the most prominently enriched metabolic pathway in GLV-infected <i>Giardia</i>. Notably, glycolysis continued to be upregulated with successive passages of GLV infection, even after the GLV load plateaued. The glycolytic enzyme enolase was found to be closely associated with GLV infection within <i>Giardia</i>, and morpholino-mediated knockdown of enolase expression resulted in a significant reduction in GLV replication. Overall, these findings demonstrate that GLV infection manipulates host translation and energy metabolic pathways to facilitate its persistence in <i>G. duodenalis</i>, and reveal both GLV and host metabolic targets as promising research subjects for developing drugs and vaccines for the prevention and treatment of giardiasis.

Background

The study addresses the role of Giardiavirus (GLV) in modulating the biology of Giardia duodenalis, a parasite linked to giardiasis, which can lead to malnutrition and growth impairment. Previous research indicated that GLV could reduce pathological damage in murine models but lacked insights into its direct effects on Giardia itself. Understanding these interactions is crucial for developing potential therapeutic strategies against giardiasis.

Methods

The study utilized a model of Giardia duodenalis infected with Giardiavirus to assess changes in protein expression and metabolic pathways. Specific metrics on sample size, dose, and duration were not reported in the abstract. Primary outcomes included mRNA and protein levels of Giardia genes and metabolic profiling of energy metabolites.

Results

The study found that GLV infection led to a reduction in both mRNA and protein levels of Giardia genes while paradoxically enhancing mRNA translation efficiency. Additionally, 21 energy metabolites were significantly altered, and glycolysis was identified as the most enriched metabolic pathway in GLV-infected Giardia.

Interpretation

The findings suggest that GLV infection significantly alters the metabolic landscape of Giardia duodenalis, particularly enhancing glycolysis. While the statistical significance of these findings is noted, the clinical relevance remains uncertain as the study does not provide direct evidence of therapeutic implications. Limitations include the lack of human data and the need for further exploration of these metabolic pathways in clinical contexts.

Key findings

  • 21 significantly altered energy metabolites identified.
  • Glycolysis/gluconeogenesis was the most prominently enriched metabolic pathway in GLV-infected Giardia.
  • Glycolysis continued to be upregulated with successive passages of GLV infection, even after the GLV load plateaued.

Limitations

  • Not reported in abstract.
  • Focus on murine models limits applicability to humans.
  • No direct evidence of clinical relevance provided.
  • Further research needed to explore therapeutic implications.

Elsewhere in the Bofanglutide corpus

DBridging Biosynthesis and Bioavailability: Integrated Strategies for Tailoring Soybean Isoflavone Profiles.Comprehensive reviews in food science and food safety · 2026reviewDSpatiotemporal dynamics of the host-tumor metabolic interface: Implications for precision nutritional oncology.Genes & diseases · 2026reviewDOne Health implementation for rabies elimination in India by 2030: Progress, governance, challenges, and policy alignment.One health (Amsterdam, Netherlands) · 2026reviewCA Ready-to-Use Recombinant Yeast Two-Hybrid Assay for Thyroxine Detection.Biosensors · 2026 · EC50 values ranged from 350 nM to 550 nM for thyroxine.In vitroCFe(III)-(II) Mineral Transformation and Associated Organic Matter Stabilization Processes in a Tidal Marsh Soil.Environmental science & technology · 2026 · Not reported in abstract.In vitroBGlobal, regional, and national burden of HIV/AIDS, 1990-2023, with the estimated burden attributable to intimate partner violence and forecasted impacts of funding cuts through 2030: results from the Global Burden of Disease Study 2023.The lancet. HIV · 2026 · 2.06 million new HIV infections globally in 2023 (1.88-2.29 million).review